Professional Documents
Culture Documents
PROVEEDORES
CUALIFICACIN DE
PROVEEDORES
PORQU
SUPPLY CHAIN
ADQUIERE CADA VEZ MAS
IMPORTANCIA?
CUALIFICACIN DE
PROVEEDORES
CUALIFICACIN DE
PROVEEDORES
CUALIFICACIN DE
PROVEEDORES
ESCENARIO ACTUAL
Cualificacin de Proveedores
Casos recientes de deficiencias en la
cualificacin, aprobacin de
suministradores de materias primas
han ocasionado catstrofes sanitarias
de mbito mundial
Ejemplo HEPARINA
CONCEPTOS
Es
Cualificacin,
homologacin, validacin,
aprobacindistintos nombres mismo objetivo
Cualificacin
de proveedores auditora
GMP
The person responsible for quality control should have responsibility together with other
relevant departments for approving suppliers who can reliably supply starting and packaging
materials that meet established specifications
Before suppliers are approved and included in the approved suppliers list or specifications,
they should be evaluated. The evaluation should take into account a suppliers history and
the nature of the materials to be supplied. If an audit is required, it should determine the
suppliers ability to conform with GMP standards
GMP
GMP
EU GMP
2 PERSONNEL
The heads of Production and Quality Control generally have some shared, or
jointly exercised, responsibilities relating to quality
..: the approval and monitoring of suppliers of materials
5 PRODUCTION
Special attention should be paid to a knowledge of the suppliers quality
assurance system in assessing the suitability of a source and the extent of
quality control testing required
GMP
For the approval and maintenance of suppliers of active substances and excipients, the
following is required:
The supply chain and traceability records
Audits should be carried out at the manufacturers and distributors
. Audits should be of an appropriate duration and scope .
. Further audits should be undertaken at intervals defined by the quality risk management .
Excipients . should be given similar attention to those for active substances
Captulo 7.17 - Outsourced activities
The Contract should permit the Contract Giver to audit outsourced activities, performed by
the Contract Acceptor or his mutually agreed subcontractors
GMP
EU GMP
GMP
7 Materials Management
Manufacturers of intermediates and/or APIs should have a system for
evaluating the suppliers of critical materials
7.3 SAMPLING AND TESTING OF INCOMING PRODUCTION MATERIALS
7.31 Supplier approval should include an evaluation that provides adequate
evidence (e.g., past quality history) that the manufacturer can consistently
provide material meeting specifications
GMP
GMP
ICH Q9
GMP
AEMPS
ACTUALMENTE
PROCESO DE CUALIFICACIN DE
PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CASOS CRTICOS:
HOSPIRA
PFIZER
BAXTER
HOSPIRA:
Recall DEBIDO A PROVEEDOR NO CUALIFICADO
The company Hospira Deutschland GmbH had to recall vials of their
antibiotic drug Meropenem. The main reason for this was that a
supplier of an important raw material was not qualified. As a result,
this manufacturer was not listed in the respective authorisation and the
batches affected did not correspond with the authorisation documents.
Nevertheless, this example shows the negative and unpleasant
consequences for companies and patients if suppliers are not or are
inadequately qualified. A change notification for the supplier to be
included in the authorisation documentation is currently in progress.
http://www.gmp-compliance.org/enews_05015_Lack-of-Supplier-Qualification-leads-to-Recall.html
PFIZER:
The New York drug maker said friday it plans to recall about 38,000
bottles of lipitor 40-milligram tablets that were distributed in the U.S.
Pfizer cited two customer reports of an uncharacteristic odor related to
the bottles, which pfizer said were supplied by a third-party bottle
manufacturer.
The latest incident follows two prior recalls of lipitor implemented in
august and earlier this month, which were also linked to complaints of
unusual odor. About 332,000 bottles of LIPITOR were recalled in those
incidents combined.
Pfizer said friday the odor is consistent with the presence of a
chemical called 2,4,6 tribromoanisole, or TBA, which was found at
a very low level in a complaint sample bottle during the probe that led
to the first recall. TBA is used as a wood preservative on pallets to
transport and store products.
PFIZER:
shortage
problems
MERCK SINEMET (tratamiento del Parkinson)
shortage
problems
J&J DOXIL (tratamiento de varios tipos de cncer)
shortage
problems
J&J DOXIL (tratamiento de varios tipos de cncer)
Doxil production hit a snag in 2011 when Boehringers plant in Ohio was forced
to shut down its manufacturing lines after the U.S. Food and Drug
Administration questioned the quality of the facilitys products.
The Delaware case is Alza Corp. v. Boehringer Ingelheim USA Corp., 8877,
Delaware Chancery Court (Wilmington).
HEPARINA
CONTAMINADA
AO 2008
HEPARINA CONTAMINADA
Ao
HEPARINA CONTAMINADA
HEPARINA CONTAMINADA
EL
PROBLEMA:
HEPARINA CONTAMINADA
EL
PROBLEMA:
HEPARINA CONTAMINADA
Porqu?
HEPARINA CONTAMINADA
Porqu?
Las autoridades chinas admitieron que la FDA CHINA
no haba inspeccionado la planta de Changzhou, la
cual estaba registrada como planta qumica, y no
estaba certificada para fabricar productos
farmacuticos.
Las companies qumicas en China no estn bajo la
jurisdiccin de la FDA CHINA.
HEPARINA CONTAMINADA
Porqu?
Si bien la planta estaba proveyendo HEPARINA a
compaias americanas por varios aos, recin fue
inspeccionada por la FDA una vez hallado el problema.
La FDA admiti que el fallo en inspeccionar la planta
China fue una violacin de sus propias polticas.
HEPARINA CONTAMINADA
Porqu?
Segn la Warning Letter de la FDA a Baxter:
the company failed to monitor changes in the impurity
profile of incoming heparin active raw material,
adequately investigate out-of-specification results,
document actual processing steps in batch records,
validate all critical steps in the process, qualify all
suppliers, and use valid methods to test products
HEPARINA CONTAMINADA
When the drug safety system fails people get sick; some die. Some of these people are already
very vulnerable and proving the cause of harm from impurities, adulteration and counterfeits can
be elusive. It is hard to detect harm; heparin required dramatic statistical spikes in
adverse event reports before problems were recognized.
I have learned in this investigation that FDA inspectors look for cultural quality at
manufacturing facilities. The FDA foreign surveillance inspections are supposed to help
encourage and ensure this culture if they happen frequently enough. Certainly the companies
are obligated to ensure a culture of quality and maintain vigilance as well. This reflects a
systems approach to safety.
The evidence we will examine today suggests this system approach wasn't at play here. FDA
policies led to the failure to inspect the Chinese plant. Baxter, which marketed the heparin,
inspected the plant for the first time just this past fall after several years of operation. This lack of
oversight provided more fertile ground for the shenanigans and the heparin counterfeits to
flourish. The FDA did a good job after the contamination, but that was too late.
CUALIFICACIN DE PROVEEDORES
Fabricantes de:
Principios activos
Excipientes
Materiales de acondicionamiento
Brokers y distribuidores
Laboratorios de anlisis
Operadores logsticos
Suministradores de software
Compaas de transporte
Contract manufacturing
CUALIFICACIN DE PROVEEDORES
Compras
Garanta de
Calidad
Logstica
Responsabilidad
es en el proceso
Control de
Calidad
I+D
Produccin
CUALIFICACIN DE PROVEEDORES
Elementos de cualificacin
-Definicin de requerimientos
-Evaluacin inicial
Perfil de la compaa
Productos y mercados
Tamao
Facturacin
Plantas de produccin
Problemas recientes
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
Anlisis
de criticidad
CUALIFICACIN
DE PROVEEDORES
CUESTIONARIO
CUALIFICACIN
DE PROVEEDORES
CUESTIONARIO
CUALIFICACIN
DE PROVEEDORES
CUESTIONARIO
CUALIFICACIN
DE PROVEEDORES
CUESTIONARIO
CUALIFICACIN
DE PROVEEDORES
CUESTIONARIO
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
Ejemplo de Frecuencia de Auditora segn Riesgo
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
AUDITORA
SEGUIMIENTO
(reporte de
retrasos
implantacin de
MC segn PAcc)
ACEPTACIN
(o negociacin)
INFORME CON
OBSERVACIONES
(usualmente se
enva antes de los
30 das)
PLAN DE ACCIN
(respuesta
usualmente antes
de los 30 das)
CUALIFICACIN DE PROVEEDORES
First party audits:
Auditoras internas
Tipos de auditoras
EL PROCESO DE
REALIZAR UNA
AUDITORIA
CUALIFICACIN DE PROVEEDORES
El
Qu vamos a auditar?
Un producto
Varios productos
Unas instalaciones
Un Sistema de Calidad
CUALIFICACIN DE PROVEEDORES
Criterios
de aceptacin
Fabricacin de excipientes
CUALIFICACIN DE PROVEEDORES
Perfil del auditor
Experiencia:
CUALIFICACIN DE PROVEEDORES
Perfil del auditor
Aptitudes personales:
CUALIFICACIN DE PROVEEDORES
Checklist
Pros
Evita la improvisacin
Contras
Impide la improvisacin
CUALIFICACIN DE PROVEEDORES
Psicologa
del auditor
CUALIFICACIN DE PROVEEDORES
Psicologa
del auditor
CUALIFICACIN DE PROVEEDORES
Visin errnea del auditor
CUALIFICACIN DE PROVEEDORES
Observaciones
Marcar en nuestras notas las observaciones para despus hacer un resumen al final
CUALIFICACIN DE PROVEEDORES
Observaciones/No
Conformidades
y su clasificacin
CUALIFICACIN DE PROVEEDORES
POTENCIALES FALLOS EN AUDITORIAS
CUALIFICACIN DE PROVEEDORES
AEMPS
Principio
CUALIFICACIN DE PROVEEDORES
TIPOS DE CONTRATOS EN LA INDUSTRIA FARMACUTICA
Contratos regulados por las GMP
Liberacin
Estudios de estabilidad
Almacenamiento y logstica
Distribucin
Transporte
CUALIFICACIN DE PROVEEDORES
TIPOS DE CONTRATOS EN LA INDUSTRIA FARMACUTICA
Contratos regulados por las GMP
Confidencialidad (*)
Ensayos clnicos
Control de plagas
Tratamiento de residuos
Farmacovigilancia
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE PROVEEDORES
CUALIFICACIN DE
PROVEEDORES
REFLEXIONES FINALES
RECOMENDACIONES
www.ich.org
ICH Guidelines
Culture of Quality
Ajaz Hussain Ex-Director FDA impulsor del cambio en 2005 hacia build quality
into the product
www.deming.org
Dr. W.Edward Deming: The 5 deadly diseases - The 14 points
www.pqg.org
A Guide to Supply Chain Risk Management
www.mckinsey.com
From Measuring Failure to Building Quality Robustness in Pharma